10th Merck Bioforum India 2022 is a thought leadership program which is a part of the flagship Asia seminar series that Merck Life Sciences has been organizing annually is being hosted in two different cities in India (on September 6th, 2022 in Pune and September 8th, 2022 in Ahmedabad), focusing on Next Generation Bioprocessing for Process Intensification.

This is an annual knowledge-sharing platform to build a network of end-users and discuss the evolving future trends of biologics manufacturing processes and technologies, challenges, and process intensification.

The move towards next-generation bioprocessing from process intensification to fully continuous processing is real and is happening now and we are all in it together. While the benefits of next-generation bioprocessing are clear, there are multiple pathways to success and many options across a range of disciplines must be considered.

For some applications and bio manufacturers, the focus will be on improving unit operation’s interoperability, for others the goal will be connected or fully continuous processing. Together with our customers and regulators, we strive to accelerate access to biopharmaceuticals for patients worldwide.

This Bioforum will provide the latest insights on delivering increased speed, greater flexibility and enhanced quality while reducing the cost, and risks of navigating the evolving biopharma landscape.

Renowned industry experts like Dr. Rustom Mody, Senior Vice President & Head R&D Biologics division, Sun Pharmaceutical Industries.; Dr. Praveen Gupta, Senior GM, Research & Development, Intas Pharmaceutical; Dr. Ashish Sahai, Additional Director, Production (viral vaccines), Serum Institute of India; Dr. Ratnesh Jain, Associate Professor, Department of Biological Sciences and Biotechnology, ICT Mumbai; and Merck experts like Dr. Subhasis Banerjee, Principal Application Expert, APAC Bioprocessing, Merck KGaA; and Dr. Simone Biel, Senior Regulatory Consultant, Merck KGaA.